Showing results (541-550 of 1,203) with videos related to
Sort By:
Pageof 121
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 30, 2022
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacementTaishi Okuno, Caglayan Demirel, Daijiro Tomii, et al.The Journal of Thoracic and Cardiovascular Surgery|August 27, 2021
Surgical versus transcatheter repair for secondary mitral regurgitation: A propensity score-matched cohorts comparisonTaishi Okuno, Fabien Praz, Mohammad Kassar, et al.JACC. Cardiovascular Interventions|July 7, 2022
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac ArrestAlessandro Spirito, Athanasios Papadis, Lukas Vaisnora, et al.Journal of the American College of Cardiology|April 16, 2011
2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesisLutz Buellesfeld, Ulrich Gerckens, Gerhard Schuler, et al.International Journal of Cardiology|March 18, 2014
Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography studyLorenz Räber, Thomas Zanchin, Sandro Baumgartner, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein graftsMasanori Taniwaki, Lorenz Räber, Michael Magro, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 16, 2023
Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trialsRayyan Hemetsberger, Nader Mankerious, Ralph Toelg, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 30, 2019
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registryGiulia Costa, Ole De Backer, Thomas Pilgrim, et al.European Heart Journal|February 25, 2012
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarctionBindu Kalesan, Thomas Pilgrim, Katja Heinimann, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 31, 2021
Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD studyNicolas M Van Mieghem, Stephan Windecker, Ganesh Manoharan, et al.Pageof 121